-
XenoPort's (XNPT) XP-829 Efficacy 'Looks Good' - RBC Capital
-
XenoPort (XNPT) Prices 12M Common Stock Offering at $6/Share
-
XenoPort (XNPT) Plans 10M Common Stock Offering
-
XenoPort (XNPT) To Offer Common Stock
-
XenoPort (XNPT) Announces 4M Common Offering
-
Notable Analyst Rating Changes 02/23: CPN, AVAV, SNI, XNPT Upgraded; PALM, BRCD, GLW, AUO, PEGA Downgraded
-
Parade of Analysts Downgrade XenoPort (XNPT) Following FDA Response Letter on Horizant
-
XenoPort (XNPT) February put volatility at 82, June at 62 into deadline
-
RBC Capital Initiates Coverage on XenoPort (XNPT) with an Outperform

